Health ❯ Public Health ❯ Infectious Diseases

Malaria

Prevention Strategies Mosquito Control Vector Control Prevention Epidemiology Outbreaks Viral Infections Humanitarian Aid Funding and Aid Ivermectin Treatment Strategies Prevention Methods World Malaria Day Prevention and Treatment Control Programs Prevention and Control Global Health Initiatives Control Strategies Vaccine Development Plasmodium Control Drug Resistance Disease Prevention Health Risks in Detention Health Risks in Conflict Zones Health Risks Imported Cases Tuberculosis Disease Control Eradication Efforts Gene Drives Mosquito-borne Diseases Campaigns Infant Health PfEMP1 Antibodies Vaccines Child Health Local Cases Transmission Urban Malaria Cases Anopheles Mosquitoes Plasmodium vivax Case Reporting Malaria Treatment Vaccination Strategies Outbreak Response Uganda Treatment Innovations Vaccination Climate Change Effects H1N1 Mosquito-Borne Diseases Chikungunya Geographic Spread

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval

The ganaplacide–lumefantrine combo could reach patients in roughly 12 to 18 months if regulators grant approval.

Pan-African Genome Map of Anopheles funestus Details Rapid Resistance and Control Targets

New Jersey Probes Possible Locally Acquired Malaria Case in Morris County

Scientists Decode First Naturally Acquired Malaria Antibody That Broadly Blocks PfEMP1–EPCR Binding

First Cryo-EM Map of Malaria Fertilization Complex Enables mRNA Vaccine Blocking 99.7% of Transmission

CRISPR Allelic-Drive Switch Renders Mosquitoes Unable to Transmit Malaria

Sexually Transmitted Fungus Kills 90% of Female Mosquitoes in Burkina Faso Trials

Researchers Develop Bed Nets with Antimalarial Compounds to Block Malaria Parasites

Researchers Identify Broad-Spectrum Inhibitors for Malaria Parasite's Key Protein Family